PAVmed Ebit Per Revenue from 2010 to 2024
| PAVMZ Stock | USD 0.01 0.0001 0.66% |
Ebit Per Revenue | First Reported 2010-12-31 | Previous Quarter (28.06) | Current Value (29.46) | Quarterly Volatility 46.51307143 |
Check PAVmed Series financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PAVmed Series' main balance sheet or income statement drivers, such as Interest Expense of 559.5 K, Selling General Administrative of 32.5 M or Other Operating Expenses of 74.8 M, as well as many indicators such as Price To Sales Ratio of 11.54, Dividend Yield of 3.0E-4 or Days Sales Outstanding of 14.05. PAVmed financial statements analysis is a perfect complement when working with PAVmed Series Valuation or Volatility modules.
PAVmed | Ebit Per Revenue |
Latest PAVmed Series' Ebit Per Revenue Growth Pattern
Below is the plot of the Ebit Per Revenue of PAVmed Series Z over the last few years. It is PAVmed Series' Ebit Per Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PAVmed Series' overall financial position and show how it may be relating to other accounts over time.
| Ebit Per Revenue | 10 Years Trend |
|
Ebit Per Revenue |
| Timeline |
PAVmed Ebit Per Revenue Regression Statistics
| Arithmetic Mean | (106.94) | |
| Coefficient Of Variation | (43.49) | |
| Mean Deviation | 20.85 | |
| Median | (108.79) | |
| Standard Deviation | 46.51 | |
| Sample Variance | 2,163 | |
| Range | 213 | |
| R-Value | 0.13 | |
| Mean Square Error | 2,291 | |
| R-Squared | 0.02 | |
| Significance | 0.65 | |
| Slope | 1.35 | |
| Total Sum of Squares | 30,289 |
PAVmed Ebit Per Revenue History
About PAVmed Series Financial Statements
PAVmed Series investors use historical fundamental indicators, such as PAVmed Series' Ebit Per Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in PAVmed Series. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Ebit Per Revenue | (28.06) | (29.46) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for PAVmed Stock Analysis
When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.